Cargando…
Trastuzumab beyond progression in HER2‐positive metastatic breast cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247876/ https://www.ncbi.nlm.nih.gov/pubmed/33472271 http://dx.doi.org/10.1111/tbj.14157 |
| _version_ | 1783716602887274496 |
|---|---|
| author | Al‐Naqqash, Manwar Jasim Al‐Serarati, Waleed Farooq Kareem, Tara |
| author_facet | Al‐Naqqash, Manwar Jasim Al‐Serarati, Waleed Farooq Kareem, Tara |
| author_sort | Al‐Naqqash, Manwar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8247876 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82478762021-07-02 Trastuzumab beyond progression in HER2‐positive metastatic breast cancer Al‐Naqqash, Manwar Jasim Al‐Serarati, Waleed Farooq Kareem, Tara Breast J Commentaries John Wiley and Sons Inc. 2021-01-20 2021-03 /pmc/articles/PMC8247876/ /pubmed/33472271 http://dx.doi.org/10.1111/tbj.14157 Text en © 2021 The Authors. The Breast Journal published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentaries Al‐Naqqash, Manwar Jasim Al‐Serarati, Waleed Farooq Kareem, Tara Trastuzumab beyond progression in HER2‐positive metastatic breast cancer |
| title | Trastuzumab beyond progression in HER2‐positive metastatic breast cancer |
| title_full | Trastuzumab beyond progression in HER2‐positive metastatic breast cancer |
| title_fullStr | Trastuzumab beyond progression in HER2‐positive metastatic breast cancer |
| title_full_unstemmed | Trastuzumab beyond progression in HER2‐positive metastatic breast cancer |
| title_short | Trastuzumab beyond progression in HER2‐positive metastatic breast cancer |
| title_sort | trastuzumab beyond progression in her2‐positive metastatic breast cancer |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247876/ https://www.ncbi.nlm.nih.gov/pubmed/33472271 http://dx.doi.org/10.1111/tbj.14157 |
| work_keys_str_mv | AT alnaqqashmanwar trastuzumabbeyondprogressioninher2positivemetastaticbreastcancer AT jasimalseraratiwaleed trastuzumabbeyondprogressioninher2positivemetastaticbreastcancer AT farooqkareemtara trastuzumabbeyondprogressioninher2positivemetastaticbreastcancer |